.png){kind=icon}
.png){kind=icon}
Return
Prospectively shared control data across concurrent randomised clinical trials
.png){kind=icon}
OA
AI
DOI：10.1016/j.ejca.2022.11.038.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Sharing data from control groups across concurrent randomised clinical trials with identical enrolment criteria and the same control therapy can translate into efficiencies for the drug development process. We discuss potential benefits and risks of prospective data-sharing plans for concurrent randomised trials.(c) 2022 Elsevier Ltd. All rights reserved.
Keywords:
Trial design
Data sharing
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.